Haben Berhane

Mr. Haben Berhane

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 March 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
HBHaben Berhane
Haben Berhane
MSMichael Scott
Michael Scott
MEMohammed Elbaz
Mohammed Elbaz
KJKelly Jarvis
Kelly Jarvis
PMPatrick McCarthy
Patrick McCarthy
MMMichael Markl
Michael Markl

26 October 2020 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
APAshitha Pathrose
Ashitha Pathrose
LMLiliana Ma
Liliana Ma
HBHaben Berhane
Haben Berhane
MSMichael B. Scott
Michael B. Scott
KCKelvin Chow
Kelvin Chow
MMMichael Markl
Michael Markl

22 November 2021 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
NHNazia Husain
Nazia Husain
KWKae Watanabe
Kae Watanabe
HBHaben Berhane
Haben Berhane
AGAditi Gupta
Aditi Gupta
MMMichael Markl
Michael Markl
Joshua D RobinosnJoshua D Robinosn
Joshua D Robinosn
The progressive risk of graft failure in pediatric heart transplantation (PHT) necessitates close surveillance for rejection and coronary allograft vasculopathy (CAV). The current gold standard of surveillance via invasive coronary angiography is costly, imperfect and associated with complications. Our goal was to assess the safety and feasibility of a comprehensive multi-parametric CMR protocol with regadenoson stress perfusion in PHT and evaluate for associations with clinical history of rejection and CAV. We performed a retrospective review of 26 PHT recipients who underwent stress CMR with tissue characterization and compared with 18 age-matched healthy controls. CMR protocol included myocardial T2, T1 and extracellular volume (ECV) mapping, late gadolinium enhancement (LGE), qualitative and semi-quantitative stress perfusion (myocardial perfusion reserve index; MPRI) and strain imaging. Clinical, demographics, rejection score and CAV history were recorded and correlated with CMR parameters. Mean age at transplant was 9.3 ± 5.5 years and median duration since transplant was 5.1 years (IQR 7.5 years). One patient had active rejection at the time of CMR, 11/26 (42%) had CAV 1 and 1/26 (4%) had CAV 2. Biventricular volumes were smaller and cardiac output higher in PHT vs. healthy controls. Global T1 (1053 ± 42 ms vs 986 ± 42 ms; p < 0.001) and ECV (26.5 ± 4.0% vs 24.0 ± 2.7%; p = 0.017) were higher in PHT compared to helathy controls. Significant relationships between changes in myocardial tissue structure and function were noted in PHT: increased T2 correlated with reduced LVEF (r = − 0.57, p = 0.005), reduced global circumferential strain (r = − 0.73, p < 0.001) and reduced global longitudinal strain (r = − 0.49, p = 0.03). In addition, significant relationships were noted between higher rejection score and global T1 (r = 0.38, p = 0.05), T2 (r = 0.39, p = 0.058) and ECV (r = 0.68, p < 0.001). The presence of even low-grade CAV was associated with higher global T1, global ECV and maximum segmental T2. No major side effects were noted with stress testing. MPRI was analyzed with good interobserver reliability and was lower in PHT compared to healthy controls (0.69 ± − 0.21 vs 0.94 ± 0.22; p < 0.001). In a PHT population with low incidence of rejection or high-grade CAV, CMR demonstrates important differences in myocardial structure, function and perfusion compared to age-matched healthy controls. Regadenoson stress perfusion CMR could be safely and reliably performed. Increasing T2 values were associated with worsening left ventricular function and increasing T1/ECV values were associated with rejection history and low-grade CAV. These findings warrant larger prospective studies to further define the role of CMR in PHT graft surveillance.

5 April 2022 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
HBHaben Berhane
Haben Berhane
MSMichael B. Scott
Michael B. Scott
ABAlex J. Barker
Alex J. Barker
PMPatrick McCarthy
Patrick McCarthy
RARyan Avery
Ryan Avery
MMMichael Markl
Michael Markl
Purpose: To develop a convolutional neural network (CNN) for the robust and fast correction of velocity aliasing in 4D‐flow MRI.Methods: This study included 667 adult subjects with aortic 4D‐flow MRI data with existing velocity aliasing (n = 362) and no velocity aliasing (n = 305). Additionally, 10 controls received back‐to‐back 4D‐flow scans with systemically varied velocity‐encoding sensitivity (vencs) at 60, 100, and 175 cm/s. The no‐aliasing data sets were used to simulate velocity aliasing by reducing the venc to 40%–70% of the original, alongside a ground truth locating all aliased voxels (153 training, 152 testing). The 152 simulated and 362 existing aliasing data sets were used for testing and compared with a conventional velocity antialiasing algorithm. Dice scores were calculated to quantify CNN performance. For controls, the venc 175‐cm/s scans were used as the ground truth and compared with the CNN‐corrected venc 60 and 100 cm/s data setsResults: The CNN required 176 ± 30 s to perform compared with 162 ± 14 s for the conventional algorithm. The CNN showed excellent performance for the simulated data compared with the conventional algorithm (median range of Dice scores CNN: [0.89–0.99], conventional algorithm: [0.84–0.94], p < 0.001, across all simulated vencs) and detected more aliased voxels in existing velocity aliasing data sets (median detected CNN: 159 voxels [31–605], conventional algorithm: 65 [7–417], p < 0.001). For controls, the CNN showed Dice scores of 0.98 [0.95–0.99] and 0.96 [0.87–0.99] for venc = 60 cm/s and 100 cm/s, respectively, while flow comparisons showed moderate‐excellent agreement.Conclusion: Deep learning enabled fast and robust velocity anti‐aliasing in 4D‐flow MRI.

30 November 2021 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
JZJiacheng Zhang
Jiacheng Zhang
SRSean M. Rothenberger
Sean M. Rothenberger
MBMelissa C. Brindise
Melissa C. Brindise
MSMichael B. Scott
Michael B. Scott
HBHaben Berhane
Haben Berhane
PVPavlos P. Vlachos
Pavlos P. Vlachos
A novel divergence-free constrained phase unwrapping method was proposed and evaluated for 4D flow MRI. The unwrapped phase field was obtained by integrating the phase variations estimated from the wrapped phase data using weighted least-squares. The divergence-free constraint for incompressible blood flow was incorporated to regulate and denoise the resulting phase field. The proposed method was tested on synthetic phase data of left ventricular flow and in vitro 4D flow measurement of Poiseuille flow. The method was additionally applied to in vivo 4D flow measurements in the thoracic aorta from 30 human subjects. The performance of the proposed method was compared to the state-of-the-art 4D single-step Laplacian algorithm. The synthetic phase data were completely unwrapped by the proposed method for all the cases with velocity encoding (venc) as low as 20% of the maximum velocity and signal-to-noise ratio as low as 5. The in vitro Poiseuille flow data were completely unwrapped with a 60% increase in the velocity-to-noise ratio. For the in-vivo aortic datasets with venc ratio less than 0.4, the proposed method significantly improved the success rate by as much as 40% and reduced the velocity error levels by a factor of 10 compared to the state-of-the-art method. The divergence-free constrained method exhibits reliability and robustness on phase unwrapping and shows improved accuracy of velocity and hemodynamic quantities by unwrapping the low-venc 4D flow MRI data.

1 September 2019 in Radiology
Verified
Journal Article
Closed access
OROzair Rahman
Ozair Rahman
MMMichael Markl
Michael Markl
PBPallavi Balte
Pallavi Balte
HBHaben Berhane
Haben Berhane
CBCarmen Blanken
Carmen Blanken
RBR. Graham Barr
R. Graham Barr
Right-heart MRI with four-dimensional flow assessment helped to demonstrate that chronic obstructive pulmonary disease was not strongly associated with changes in venous flow to the right heart, bu... BackgroundChronic obstructive pulmonary disease (COPD) is associated with hemodynamic changes in the pulmonary vasculature. However, cardiac effects are not fully understood and vary by phenotype o...